4th Quarter - Report

JAMES EDWARDS for CONSERVATIVES FOR PROPERTY RIGHTS

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Roads/Highway ROD

H.R. 2962 (Americas Infrastructure Modernization (AIM) Act) H.R. 3684 (INVEST in America Act)

LobbyistCovered position, as disclosed
JAMES R EDWARDS LD, Rep. Ed Bryant; LA/Press Secretary, Rep. John Duncan; Special Assistant, Senate Judiciary Committee

Contacted: Patent & Trademark Office (PTO); SENATE; HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC)

Bills named: H.R. 2962 (117th), H.R. 3684 (117th)

Taxation/Internal Revenue Code TAX

S. 617/H.R. 1712 (Death Tax Repeal Act) Tax provisions, namely capital gains confiscatory scheme, in Biden "American Families Plan S.Con.Res. 14 (FY 2022 Budget Resolution) tax provisions for capital gains tax rate increase, taxing trusts, step up in basis repeal, taxing unrealized assets upon death (double death tax), 95 percent tax on those pharmaceuticals sold at fair market value H.R. 5376 (FY 2022 Budget Reconciliation) tax provisions for capital gains tax rate increase, taxing trusts, step up in basis repeal, taxing unrealized assets upon death (double death tax), taxing unrealized capital gains, accelerated expiration of current estate and gift tax exemption levels, tax treatment changes of grantor retained annuity trusts (GRATS), valuation rules changes that ignore discounts from partial ownership or lack of control of an asset, 95 percent tax on those pharmaceuticals sold at fair market value H.R. 5649 (BEAT CHINA Act)

LobbyistCovered position, as disclosed
JAMES R EDWARDS LD, Rep. Ed Bryant; LA/Press Secretary, Rep. John Duncan; Special Assistant, Senate Judiciary Committee

Contacted: SENATE; Patent & Trademark Office (PTO); Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES

Bills named: S. 617 (117th), S.Con.Res. 14 (117th), H.R. 5649 (117th), H.R. 5376 (117th), H.R. 1712 (117th)

Copyright/Patent/Trademark CPT

STRONGER Patents Act National Institute of Standards and Technology (NIST) proposed revisions to Rights to Inventions Made by Nonprofit Organizations and Small Business Firms under Government Grants, Contracts, and Cooperative Agreements and Licensing of Government-Owned Inventions (NIST Docket No. 201207-0327) Federal position on proposal at World Trade Organization to waive intellectual property protections due under Trade-Related Aspects of Intellectual Property Rights Agreement with regard to COVID-19-related inventions H.R. 3035/S. 1683 (Preventing Foreign Attempts to Erode Healthcare Innovation Act) S. 1260 (Endless Frontier Act/United States Innovation and Competition Act) patent and intellectual property-related provisions and amendments H.R. 4792 (Countering Communist China Act) patent and intellectual property-related provisions Request for Information Regarding Patent Eligibility Jurisprudence Study (Docket No. PTO-P-2021-0032) Bayh-Dole Act march-in misuse demands
 Patent & Trademark Office/PTAB discretion to institute or to deny trials before the Patent Trial and Appeal Board, pursuant to America Invents Act discretion; PTAB designation of precedential opinions, including the Fintiv doctrine to avoid duplicative litigation on the same patent claims in multiple forums S. 2891 (Restoring the America Invents Act) S. 2774 (Pride in Patent Ownership) H.R. 5874 (Restoring Americas Leadership in Innovation Act)

LobbyistCovered position, as disclosed
JAMES R EDWARDS LD, Rep. Ed Bryant; LA/Press Secretary, Rep. John Duncan; Special Assistant, Senate Judiciary Committee

Contacted: Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; SENATE; Federal Trade Commission (FTC)

Bills named: S. 1260 (117th), S. 2774 (117th), H.R. 3035 (117th), S. 1683 (117th), H.R. 5874 (117th), S. 2891 (117th), H.R. 4792 (117th)

Economics/Economic Development ECN

H.R. 5376 (FY 2022 Budget Reconciliation) inflationary provisions and effects

LobbyistCovered position, as disclosed
JAMES R EDWARDS LD, Rep. Ed Bryant; LA/Press Secretary, Rep. John Duncan; Special Assistant, Senate Judiciary Committee

Contacted: HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); Patent & Trademark Office (PTO); SENATE

Bills named: H.R. 5376 (117th)

Government Issues GOV

Senate filibuster rules for the protection of minority rights to debate S. 2428 (False Claims Act Amendments)

LobbyistCovered position, as disclosed
JAMES R EDWARDS LD, Rep. Ed Bryant; LA/Press Secretary, Rep. John Duncan; Special Assistant, Senate Judiciary Committee

Contacted: HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); SENATE; Patent & Trademark Office (PTO)

Bills named: S. 2428 (117th)

Clean Air and Water (quality) CAW

EPA review of secondary National Ambient Air Quality Standards, pursuant to Clean Air Act, as backdoor Green New Deal elements H.R. 5376 (FY 2022 Budget Reconciliation) Green New Deal-related provisions assaulting established, proven domestic energy sectors

LobbyistCovered position, as disclosed
JAMES R EDWARDS LD, Rep. Ed Bryant; LA/Press Secretary, Rep. John Duncan; Special Assistant, Senate Judiciary Committee

Contacted: Federal Trade Commission (FTC); SENATE; HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO)

Bills named: H.R. 5376 (117th)

Real Estate/Land Use/Conservation RES

H.R. 803 (Protecting America's Wilderness and Public Lands Act) H.R. 859 (Protecting American Energy Jobs Act) H.R. 3014 (30 x 30 Termination Act) Executive Order 14008, Sec. 216 30 x 30 radical land grab program EPA declaration requesting remand of the 2020 Navigable Waters Protection Rule

LobbyistCovered position, as disclosed
JAMES R EDWARDS LD, Rep. Ed Bryant; LA/Press Secretary, Rep. John Duncan; Special Assistant, Senate Judiciary Committee

Contacted: SENATE; Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO)

Bills named: H.R. 803 (117th), H.R. 859 (117th), H.R. 3014 (117th)

Medicare/Medicaid MMM

Price controls proposals regarding pharmaceuticals or other medical goods or services H.R. 3 (Lower Drug Costs Now Act) Interim Final Rule implementing a Most Favored Nation (MFN) Model for importing foreign price controls for certain Medicare Part B drugs (CMS-5528-IFC) S.Con.Res. 14 (FY22 Budget Resolution) price control provisions to repeal noninterference clause in Medicare Parts C & D H.R. 2884 (Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act) H.R. 5237 (Reduced Costs and Continued Cures Act) H.R. 5376 (FY 2022 Budget Reconciliation) price control provisions from H.R. 3, including repeal of noninterference clause in Medicare Parts C & D, and provisions expanding government-run health care, restrictions on private, Medicare, and Medicaid rates, coverage, and reimbursement, Medicare program changes reducing beneficiary choice, plan design, and competition

LobbyistCovered position, as disclosed
JAMES R EDWARDS LD, Rep. Ed Bryant; LA/Press Secretary, Rep. John Duncan; Special Assistant, Senate Judiciary Committee

Contacted: SENATE; Patent & Trademark Office (PTO); Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES

Bills named: H.R. 5237 (117th), S.Con.Res. 14 (117th), H.R. 3 (117th), H.R. 5376 (117th), H.R. 2884 (117th)

Labor Issues/Antitrust/Workplace LBR

Antitrust Consumer welfare standard S. 225 (Competition and Antitrust Law Enforcement Reform Act) H.R. 842 (Protecting the Right to Organize (PRO) Act) H.R. 3460/S. 1787 (State Antitrust Enforcement Venue Act) H.R. 3816/S. 2992 (American Choice and Innovation Online Act) H.R. 3825 (Ending Platform Monopolies Act) H.R. 3826 (Platform Competition and Opportunity Act) H.R. 3843 (Merger Filing Fee Modernization Act) H.R. 3849 (ACCESS Act) House Judiciary Comm. Final Report on Investigation of Competition in Digital Markets S. 1435/H.R. 2873 (Affordable Prescriptions for Patients Through Promoting Competition Act) S. 1425/H.R. 2883 (Stop STALLING Act) S. 1428/H.R. 2891 (Preserve Access to Affordable Generics) Federal Trade Commission motion to rescind the 2015 Statement of Enforcement Principles Regarding Unfair Methods of Competition (UMC) Under Section 5 of the FTC Act Multilateral Pharmaceutical Merger Task Force (FTC Pharmaceutical Task Force, Project No. P212900) Executive Order 14036 (Promoting Competition in the American Economy) FTC Rescission of 1995 Policy Statement on Prior Approval and Prior Notice Provisions in Merger Cases FTCs counting votes cast by a former commissioner

LobbyistCovered position, as disclosed
JAMES R EDWARDS LD, Rep. Ed Bryant; LA/Press Secretary, Rep. John Duncan; Special Assistant, Senate Judiciary Committee

Contacted: Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; SENATE; Patent & Trademark Office (PTO)

Bills named: S. 1787 (117th), H.R. 3826 (117th), S. 225 (117th), H.R. 3849 (117th), S. 1428 (117th), H.R. 2873 (117th), S. 1425 (117th), H.R. 3816 (117th), H.R. 2883 (117th), H.R. 3843 (117th), H.R. 3825 (117th), H.R. 842 (117th), H.R. 3460 (117th), S. 1435 (117th), H.R. 2891 (117th), S. 2992 (117th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.